Medical Countermeasures U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC OutbreakGlobal Biodefense StaffJune 12, 2026
Medical Countermeasures CEPI Funds Three Bundibugyo Ebolavirus Vaccine Candidates, Including Oxford’s ChAdOx1-Based ApproachGlobal Biodefense StaffJune 1, 2026
Medical Countermeasures The Mpox Vaccine Works — But Its Immunity Fades Fast. A Third Dose May Help.Global Biodefense StaffMay 19, 2026
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses Medical Countermeasures February 15, 2020 …
Scientists Test Drugs Against Virus Samples from First U.S. COVID-19 Patient Medical Countermeasures February 15, 2020 …
China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19 Medical Countermeasures February 15, 2020 …
Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of SARS-CoV-2 Medical Countermeasures February 12, 2020 …
Insilico Medicine Publishes Molecular Structures for Key Protein Target of SARS-CoV-2 Medical Countermeasures February 6, 2020 …
HHS, Regeneron Collaborate to Develop COVID-19 Treatment Using VelociSuite Technology Medical Countermeasures February 4, 2020 …
First-Ever Therapeutic Antibody Cocktail for Sudan Virus Shows Promise in Animal Studies Medical Countermeasures February 4, 2020 …
Seqirus’ Pandemic Flu Vaccine Approved: Next Generation Technology Strengthens Preparedness Medical Countermeasures February 3, 2020 …
BARDA Seeks Input from Suppliers on Potential SARS-CoV-2 Medical Countermeasures Contracts + Grants February 2, 2020 …
CureVac and CEPI Extend Their Cooperation to Develop a Vaccine Against COVID-19 Medical Countermeasures January 31, 2020 …
NanoViricides Confirms It Has Been Working On Treatment for Novel Coronavirus Medical Countermeasures January 30, 2020 …
Inovio, Beijing Advaccine Collaborate to Advance INO-4800 Vaccine Medical Countermeasures January 30, 2020 …
AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program Medical Countermeasures January 29, 2020 …
Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV Medical Countermeasures January 24, 2020 …
CEPI to Fund Development of Multiple Candidate Vaccines Against the Novel Coronavirus Medical Countermeasures January 23, 2020 …
